載入...

Repeated intratumoral administration of ONCOS-102 leads to systemic antitumor CD8(+) T-cell response and robust cellular and transcriptional immune activation at tumor site in a patient with ovarian cancer

Adenoviruses are excellent immunotherapeutic agents with a unique ability to prime and boost immune responses. Recombinant adenoviruses cause immunogenic cancer cell death and subsequent release of tumor antigens for antigen presenting cells, resulting in the priming of potent tumor-specific immunit...

全面介紹

Na minha lista:
書目詳細資料
發表在:Oncoimmunology
Main Authors: Vassilev, L, Ranki, T, Joensuu, T, Jäger, E, Karbach, J, Wahle, C, Partanen, K, Kairemo, K, Alanko, T, Turkki, R, Linder, N, Lundin, J, Ristimäki, A, Kankainen, M, Hemminki, A, Backman, C, Dienel, K, von Euler, M, Haavisto, E, Hakonen, T, Juhila, J, Jäderberg, M, Priha, P, Vuolanto, A, Pesonen, S
格式: Artigo
語言:Inglês
出版: Taylor & Francis 2015
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4485730/
https://ncbi.nlm.nih.gov/pubmed/26140248
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2015.1017702
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!